Naproxen Suspension
Product Images NDC 59651-528

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 59651-528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Naproxen Fig1)

Fig1 (Naproxen Fig1)
This text is a description of Naproxen Oral Suspension, USP. It provides information about the medication, dosage, storage instructions, and where to find the Medication Guide. It also includes details on the manufacturer, distributor, and production details. The medication contains Naproxen USP 125 mg per 5 mL of oral suspension. It is important to shake the product well before using and to store it within the recommended temperature range. Additionally, it alerts users not to use the product if the tamper-evident seal is separated or missing.*
FDA Label Image

Package Label-principal Display Panel (125 mg/5 mL (473 mL Carton Label))

Package Label-principal Display Panel (125 mg/5 mL (473 mL Carton Label))
This is a description for Naproxen Oral Suspension, USP, a medication indicated for relieving the signs and symptoms of various conditions such as rheumatoid arthritis, osteoarthritis, tendonitis, and bursitis, among others. It is also used for pain management and primary dysmenorrhea. Each 5 mL of the suspension contains 125 mg of Naproxen USP. The recommended dosage should be followed as per the prescribing information provided with the medication guide. The suspension should be stored within specified temperature ranges and dispensed in a light-resistant container. Not to be used if tamper-evident seal is broken or missing. This medication is distributed by Aurobindo Pharma USA, Inc., and manufactured in India. It is recommended for Juvenile Rheumatoid Arthritis with specific dosing guidance provided in the prescribing information.*
FDA Label Image

Str (Naproxen Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.